| Agewell Geriatrics | |
|
793 Nw 1621st Rd Bates City MO 64011-8395 | |
| (816) 226-1182 | |
| Not Available |
| Full Name | Agewell Geriatrics |
|---|---|
| Speciality | Family Medicine |
| Location | 793 Nw 1621st Rd, Bates City, Missouri |
| Authorized Official Name and Position | James Lawrenzi (PHYSICIAN) |
| Authorized Official Contact | 8162261182 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Agewell Geriatrics 793 Nw 1621st Rd Bates City MO 64011-8395 Ph: (816) 226-1182 | Agewell Geriatrics 793 Nw 1621st Rd Bates City MO 64011-8395 Ph: (816) 226-1182 |
| NPI Number | 1447027362 |
|---|---|
| Provider Enumeration Date | 12/11/2023 |
| Last Update Date | 12/11/2023 |
| Medicare PECOS PAC ID | 0244681633 |
|---|---|
| Medicare Enrollment ID | O20240110002534 |
News Archive
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.
Music as medicine has become a more widely adopted concept over the years and considered as complementary therapy for a number of health issues.
Results of a study co-authored by MGH Institute of Health Professions researcher Teresa Kimberley, PhD, PT, have the potential to be one of the most impressive advances in decades to help improve the lives of patients who have had a stroke with resulting arm weakness.
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447027362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | (* (Not Available)) | Primary |
| Provider Name | James D Lawrenzi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1174550313 PECOS PAC ID: 0941357669 Enrollment ID: I20090416000097 |
News Archive
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.
Music as medicine has become a more widely adopted concept over the years and considered as complementary therapy for a number of health issues.
Results of a study co-authored by MGH Institute of Health Professions researcher Teresa Kimberley, PhD, PT, have the potential to be one of the most impressive advances in decades to help improve the lives of patients who have had a stroke with resulting arm weakness.
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
› Verified 5 days ago
News Archive
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.
Music as medicine has become a more widely adopted concept over the years and considered as complementary therapy for a number of health issues.
Results of a study co-authored by MGH Institute of Health Professions researcher Teresa Kimberley, PhD, PT, have the potential to be one of the most impressive advances in decades to help improve the lives of patients who have had a stroke with resulting arm weakness.
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
› Verified 5 days ago
The Neighborhood Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 203 E Market St, Bates City, MO 64011 Phone: 816-896-0416 Fax: 816-690-3147 |